Concepts (297)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otolaryngology | 10 | 2020 | 10 | 3.740 |
Why?
|
| Humans | 49 | 2020 | 4931 | 1.800 |
Why?
|
| Bibliometrics | 4 | 2014 | 8 | 1.680 |
Why?
|
| Biomedical Research | 5 | 2014 | 17 | 1.440 |
Why?
|
| Tonsillectomy | 4 | 2013 | 4 | 1.280 |
Why?
|
| Financing, Government | 4 | 2014 | 9 | 1.240 |
Why?
|
| Publishing | 3 | 2013 | 8 | 1.220 |
Why?
|
| Male | 25 | 2019 | 2620 | 1.110 |
Why?
|
| Head and Neck Neoplasms | 4 | 2016 | 11 | 1.050 |
Why?
|
| Female | 24 | 2019 | 2964 | 1.030 |
Why?
|
| Research Support as Topic | 4 | 2014 | 18 | 1.010 |
Why?
|
| United States | 17 | 2019 | 764 | 1.000 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2015 | 58 | 0.950 |
Why?
|
| Thyroid Diseases | 3 | 2014 | 6 | 0.950 |
Why?
|
| Retrospective Studies | 13 | 2020 | 513 | 0.920 |
Why?
|
| Postoperative Hemorrhage | 3 | 2013 | 5 | 0.870 |
Why?
|
| Protein Aggregates | 1 | 2023 | 1 | 0.870 |
Why?
|
| Adolescent | 13 | 2017 | 569 | 0.870 |
Why?
|
| Authorship | 2 | 2014 | 3 | 0.870 |
Why?
|
| Thyroidectomy | 2 | 2014 | 4 | 0.860 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2023 | 17 | 0.850 |
Why?
|
| Periodicals as Topic | 2 | 2013 | 10 | 0.810 |
Why?
|
| Otorhinolaryngologic Diseases | 2 | 2019 | 2 | 0.720 |
Why?
|
| Health Care Costs | 3 | 2020 | 30 | 0.710 |
Why?
|
| Device Removal | 1 | 2020 | 1 | 0.700 |
Why?
|
| Catheterization | 1 | 2020 | 6 | 0.700 |
Why?
|
| Spinal Cord Injuries | 1 | 2020 | 5 | 0.700 |
Why?
|
| Adult | 13 | 2018 | 1402 | 0.700 |
Why?
|
| Medicare | 4 | 2015 | 45 | 0.680 |
Why?
|
| Postoperative Complications | 4 | 2014 | 82 | 0.630 |
Why?
|
| Practice Guidelines as Topic | 3 | 2014 | 69 | 0.610 |
Why?
|
| Child | 7 | 2017 | 336 | 0.580 |
Why?
|
| Middle Aged | 13 | 2019 | 1544 | 0.570 |
Why?
|
| Guidelines as Topic | 2 | 2017 | 15 | 0.550 |
Why?
|
| Primary Health Care | 2 | 2017 | 64 | 0.550 |
Why?
|
| Bacterial Infections | 2 | 2014 | 7 | 0.520 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2014 | 6 | 0.520 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2015 | 34 | 0.500 |
Why?
|
| von Willebrand Diseases | 2 | 2013 | 2 | 0.500 |
Why?
|
| Health Services Research | 2 | 2013 | 24 | 0.500 |
Why?
|
| Internet | 2 | 2013 | 22 | 0.490 |
Why?
|
| Fee-for-Service Plans | 1 | 2015 | 8 | 0.480 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 2015 | 1 | 0.470 |
Why?
|
| Research Design | 1 | 2015 | 32 | 0.460 |
Why?
|
| Skull Fractures | 2 | 2012 | 3 | 0.460 |
Why?
|
| Women | 1 | 2014 | 4 | 0.450 |
Why?
|
| Medical Oncology | 1 | 2014 | 8 | 0.440 |
Why?
|
| Peritonsillar Abscess | 1 | 2014 | 1 | 0.440 |
Why?
|
| Retropharyngeal Abscess | 1 | 2014 | 1 | 0.440 |
Why?
|
| Soft Tissue Infections | 1 | 2014 | 3 | 0.440 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 37 | 0.440 |
Why?
|
| Robotics | 1 | 2014 | 3 | 0.440 |
Why?
|
| Risk Assessment | 5 | 2018 | 162 | 0.440 |
Why?
|
| Bronchoscopy | 1 | 2013 | 1 | 0.430 |
Why?
|
| Hospitals, High-Volume | 1 | 2013 | 1 | 0.430 |
Why?
|
| Esophagoscopy | 1 | 2013 | 3 | 0.430 |
Why?
|
| Inpatients | 1 | 2013 | 17 | 0.420 |
Why?
|
| Disclosure | 1 | 2013 | 2 | 0.420 |
Why?
|
| Conflict of Interest | 1 | 2013 | 2 | 0.420 |
Why?
|
| Quality Improvement | 1 | 2013 | 27 | 0.420 |
Why?
|
| Publications | 1 | 2013 | 3 | 0.420 |
Why?
|
| Neck Dissection | 1 | 2013 | 1 | 0.420 |
Why?
|
| Child, Preschool | 5 | 2014 | 177 | 0.410 |
Why?
|
| Models, Anatomic | 1 | 2013 | 7 | 0.410 |
Why?
|
| Research | 1 | 2013 | 21 | 0.410 |
Why?
|
| Hemophilia A | 1 | 2013 | 1 | 0.410 |
Why?
|
| Patient Education as Topic | 2 | 2014 | 49 | 0.410 |
Why?
|
| Education, Medical, Graduate | 1 | 2013 | 21 | 0.410 |
Why?
|
| Patient Protection and Affordable Care Act | 2 | 2014 | 4 | 0.410 |
Why?
|
| Drug Industry | 1 | 2012 | 5 | 0.400 |
Why?
|
| Public Policy | 1 | 2012 | 5 | 0.400 |
Why?
|
| Comprehension | 1 | 2012 | 7 | 0.400 |
Why?
|
| Smell | 1 | 2012 | 2 | 0.390 |
Why?
|
| Maxillofacial Injuries | 1 | 2012 | 1 | 0.380 |
Why?
|
| Free Tissue Flaps | 1 | 2012 | 6 | 0.380 |
Why?
|
| Wounds, Gunshot | 1 | 2012 | 15 | 0.380 |
Why?
|
| Ear, Inner | 1 | 2011 | 2 | 0.380 |
Why?
|
| Electronic Health Records | 1 | 2012 | 24 | 0.370 |
Why?
|
| Alzheimer Disease | 1 | 2012 | 26 | 0.370 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 29 | 0.370 |
Why?
|
| Skull Fracture, Basilar | 1 | 2011 | 1 | 0.370 |
Why?
|
| Carotid Artery Injuries | 1 | 2011 | 2 | 0.370 |
Why?
|
| Temporal Bone | 1 | 2011 | 2 | 0.360 |
Why?
|
| Multiple Trauma | 1 | 2011 | 5 | 0.360 |
Why?
|
| Cervical Vertebrae | 1 | 2011 | 4 | 0.360 |
Why?
|
| Brain Injuries | 1 | 2011 | 9 | 0.360 |
Why?
|
| Treatment Outcome | 5 | 2018 | 402 | 0.360 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2011 | 1 | 0.360 |
Why?
|
| Young Adult | 5 | 2017 | 382 | 0.360 |
Why?
|
| Adenoidectomy | 1 | 2011 | 1 | 0.360 |
Why?
|
| Blood Coagulation Disorders | 1 | 2011 | 4 | 0.350 |
Why?
|
| Cohort Studies | 6 | 2015 | 224 | 0.350 |
Why?
|
| Endolymphatic Sac | 1 | 2010 | 1 | 0.340 |
Why?
|
| Mastoid | 1 | 2010 | 1 | 0.340 |
Why?
|
| Meniere Disease | 1 | 2010 | 1 | 0.340 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2010 | 1 | 0.340 |
Why?
|
| Sinusitis | 1 | 2010 | 2 | 0.330 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 358 | 0.330 |
Why?
|
| Hearing Loss | 1 | 2010 | 8 | 0.330 |
Why?
|
| Databases, Factual | 4 | 2015 | 60 | 0.330 |
Why?
|
| Follow-Up Studies | 5 | 2016 | 202 | 0.330 |
Why?
|
| Chondroma | 1 | 2009 | 1 | 0.320 |
Why?
|
| Enchondromatosis | 1 | 2009 | 1 | 0.320 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2009 | 1 | 0.320 |
Why?
|
| Petrous Bone | 1 | 2009 | 1 | 0.320 |
Why?
|
| Sphenoid Sinus | 1 | 2009 | 1 | 0.320 |
Why?
|
| Medicaid | 3 | 2014 | 14 | 0.310 |
Why?
|
| Length of Stay | 3 | 2014 | 34 | 0.300 |
Why?
|
| Respiration, Artificial | 2 | 2020 | 11 | 0.280 |
Why?
|
| Risk Factors | 4 | 2016 | 593 | 0.280 |
Why?
|
| Tracheostomy | 2 | 2020 | 4 | 0.270 |
Why?
|
| Referral and Consultation | 2 | 2019 | 45 | 0.270 |
Why?
|
| Perilymph | 1 | 2006 | 1 | 0.260 |
Why?
|
| Lightning Injuries | 1 | 2006 | 1 | 0.260 |
Why?
|
| Fistula | 1 | 2006 | 2 | 0.260 |
Why?
|
| Cost-Benefit Analysis | 2 | 2018 | 40 | 0.250 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2011 | 43 | 0.250 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 2 | 2019 | 2 | 0.240 |
Why?
|
| Age Factors | 3 | 2014 | 152 | 0.230 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2016 | 15 | 0.230 |
Why?
|
| Tinnitus | 2 | 2014 | 3 | 0.230 |
Why?
|
| Infant | 3 | 2013 | 132 | 0.230 |
Why?
|
| Sex Factors | 3 | 2014 | 120 | 0.220 |
Why?
|
| Mitochondrial Dynamics | 1 | 2023 | 1 | 0.220 |
Why?
|
| Organelles | 1 | 2023 | 2 | 0.220 |
Why?
|
| Cell Division | 1 | 2023 | 35 | 0.220 |
Why?
|
| Mitochondria | 1 | 2023 | 21 | 0.210 |
Why?
|
| Aged | 5 | 2018 | 1188 | 0.200 |
Why?
|
| Age Distribution | 2 | 2014 | 33 | 0.200 |
Why?
|
| Sex Distribution | 2 | 2014 | 35 | 0.200 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 76 | 0.190 |
Why?
|
| Incidence | 2 | 2014 | 141 | 0.190 |
Why?
|
| Audiometry, Pure-Tone | 2 | 2011 | 2 | 0.170 |
Why?
|
| Private Sector | 1 | 2019 | 1 | 0.160 |
Why?
|
| Public Sector | 1 | 2019 | 1 | 0.160 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 17 | 0.160 |
Why?
|
| Endoscopy | 2 | 2010 | 6 | 0.160 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 33 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2010 | 41 | 0.160 |
Why?
|
| Cetuximab | 1 | 2018 | 1 | 0.140 |
Why?
|
| Bevacizumab | 1 | 2018 | 4 | 0.140 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 17 | 0.140 |
Why?
|
| Writing | 1 | 2017 | 2 | 0.140 |
Why?
|
| Checklist | 1 | 2017 | 2 | 0.140 |
Why?
|
| Medical Records | 1 | 2017 | 21 | 0.140 |
Why?
|
| Comorbidity | 2 | 2015 | 123 | 0.130 |
Why?
|
| Insurance, Health | 2 | 2014 | 23 | 0.130 |
Why?
|
| Neoplasms, Second Primary | 1 | 2016 | 1 | 0.130 |
Why?
|
| Asia | 2 | 2014 | 2 | 0.130 |
Why?
|
| Budgets | 2 | 2014 | 4 | 0.130 |
Why?
|
| SEER Program | 1 | 2016 | 6 | 0.130 |
Why?
|
| Prognosis | 2 | 2018 | 167 | 0.130 |
Why?
|
| Hypophysectomy | 1 | 2015 | 1 | 0.120 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2015 | 1 | 0.120 |
Why?
|
| ACTH-Secreting Pituitary Adenoma | 1 | 2015 | 1 | 0.120 |
Why?
|
| Dopamine Agonists | 1 | 2015 | 2 | 0.120 |
Why?
|
| Radiotherapy | 1 | 2015 | 2 | 0.120 |
Why?
|
| Adenoma | 1 | 2015 | 6 | 0.120 |
Why?
|
| Adrenalectomy | 1 | 2015 | 10 | 0.120 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2015 | 2 | 0.120 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2015 | 6 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 5 | 0.120 |
Why?
|
| Risk | 1 | 2015 | 39 | 0.120 |
Why?
|
| Asthma | 1 | 2015 | 17 | 0.120 |
Why?
|
| Prevalence | 2 | 2016 | 184 | 0.120 |
Why?
|
| Orthopedic Procedures | 1 | 2014 | 2 | 0.110 |
Why?
|
| Eligibility Determination | 1 | 2014 | 4 | 0.110 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 24 | 0.110 |
Why?
|
| Neck | 1 | 2014 | 3 | 0.110 |
Why?
|
| Thyroid Nodule | 1 | 2014 | 2 | 0.110 |
Why?
|
| Thyroid Neoplasms | 1 | 2014 | 2 | 0.110 |
Why?
|
| Operative Time | 1 | 2014 | 6 | 0.110 |
Why?
|
| Postoperative Care | 1 | 2014 | 5 | 0.110 |
Why?
|
| Pain, Postoperative | 1 | 2014 | 19 | 0.110 |
Why?
|
| Specialization | 1 | 2014 | 14 | 0.110 |
Why?
|
| Health Expenditures | 1 | 2014 | 14 | 0.110 |
Why?
|
| Costs and Cost Analysis | 1 | 2013 | 13 | 0.110 |
Why?
|
| Total Quality Management | 1 | 2013 | 1 | 0.110 |
Why?
|
| Michigan | 1 | 2013 | 5 | 0.110 |
Why?
|
| Hypothyroidism | 1 | 2014 | 22 | 0.110 |
Why?
|
| Access to Information | 1 | 2013 | 3 | 0.110 |
Why?
|
| Surgery Department, Hospital | 1 | 2013 | 1 | 0.110 |
Why?
|
| Organ Sparing Treatments | 1 | 2013 | 3 | 0.110 |
Why?
|
| Financial Support | 1 | 2013 | 1 | 0.110 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2013 | 6 | 0.100 |
Why?
|
| Cost Savings | 1 | 2013 | 12 | 0.100 |
Why?
|
| MEDLINE | 1 | 2013 | 5 | 0.100 |
Why?
|
| Health Care Surveys | 1 | 2013 | 21 | 0.100 |
Why?
|
| Equipment Design | 1 | 2013 | 16 | 0.100 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 146 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 124 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 35 | 0.100 |
Why?
|
| Hospitalization | 1 | 2014 | 106 | 0.100 |
Why?
|
| Organizations, Nonprofit | 1 | 2012 | 1 | 0.100 |
Why?
|
| Quality Control | 1 | 2012 | 1 | 0.100 |
Why?
|
| Prospective Studies | 1 | 2013 | 229 | 0.100 |
Why?
|
| Taxes | 1 | 2012 | 2 | 0.100 |
Why?
|
| Delivery of Health Care | 1 | 2012 | 55 | 0.100 |
Why?
|
| Cosmetic Techniques | 1 | 2012 | 3 | 0.100 |
Why?
|
| American Recovery and Reinvestment Act | 1 | 2012 | 1 | 0.100 |
Why?
|
| Bone Wires | 1 | 2012 | 1 | 0.100 |
Why?
|
| Debridement | 1 | 2012 | 1 | 0.100 |
Why?
|
| Mandibular Injuries | 1 | 2012 | 1 | 0.100 |
Why?
|
| Nose | 1 | 2012 | 1 | 0.100 |
Why?
|
| Jaw Fixation Techniques | 1 | 2012 | 1 | 0.100 |
Why?
|
| Fascia | 1 | 2012 | 2 | 0.100 |
Why?
|
| Bone Transplantation | 1 | 2012 | 2 | 0.100 |
Why?
|
| Fracture Fixation, Internal | 1 | 2012 | 2 | 0.100 |
Why?
|
| Bone Plates | 1 | 2012 | 2 | 0.100 |
Why?
|
| Orbit | 1 | 2012 | 5 | 0.100 |
Why?
|
| Insurance Coverage | 1 | 2012 | 12 | 0.100 |
Why?
|
| Medical Informatics | 1 | 2012 | 6 | 0.100 |
Why?
|
| Skin Transplantation | 1 | 2012 | 3 | 0.100 |
Why?
|
| Hyperplasia | 1 | 2011 | 5 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 1 | 2012 | 16 | 0.090 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2011 | 4 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 93 | 0.090 |
Why?
|
| Motivation | 1 | 2012 | 31 | 0.090 |
Why?
|
| Thyroid Gland | 1 | 2011 | 5 | 0.090 |
Why?
|
| Graft Survival | 1 | 2012 | 34 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2012 | 56 | 0.090 |
Why?
|
| Cerebral Angiography | 1 | 2011 | 1 | 0.090 |
Why?
|
| Glasgow Coma Scale | 1 | 2011 | 3 | 0.090 |
Why?
|
| Physicians | 1 | 2012 | 37 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2011 | 46 | 0.090 |
Why?
|
| Facial Dermatoses | 1 | 2011 | 1 | 0.090 |
Why?
|
| Granuloma | 1 | 2011 | 1 | 0.090 |
Why?
|
| Organophosphonates | 1 | 2011 | 1 | 0.090 |
Why?
|
| Cytosine | 1 | 2011 | 2 | 0.090 |
Why?
|
| Off-Label Use | 1 | 2011 | 2 | 0.090 |
Why?
|
| Bone Diseases, Developmental | 1 | 2011 | 1 | 0.090 |
Why?
|
| Cochlear Implants | 1 | 2011 | 1 | 0.090 |
Why?
|
| Ear Canal | 1 | 2011 | 1 | 0.090 |
Why?
|
| Hypertelorism | 1 | 2011 | 1 | 0.090 |
Why?
|
| Incus | 1 | 2011 | 1 | 0.090 |
Why?
|
| Speech Perception | 1 | 2011 | 1 | 0.090 |
Why?
|
| Otologic Surgical Procedures | 1 | 2011 | 1 | 0.090 |
Why?
|
| Hyperostosis | 1 | 2011 | 1 | 0.090 |
Why?
|
| Craniofacial Abnormalities | 1 | 2011 | 1 | 0.090 |
Why?
|
| Tympanic Membrane | 1 | 2011 | 3 | 0.090 |
Why?
|
| Emergency Treatment | 1 | 2011 | 2 | 0.090 |
Why?
|
| Partial Thromboplastin Time | 1 | 2011 | 3 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2011 | 10 | 0.090 |
Why?
|
| Blood Transfusion | 1 | 2011 | 8 | 0.090 |
Why?
|
| Hospitals, Pediatric | 1 | 2011 | 7 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2011 | 53 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 51 | 0.080 |
Why?
|
| Tracheitis | 1 | 2010 | 1 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2010 | 2 | 0.080 |
Why?
|
| Paranasal Sinuses | 1 | 2010 | 1 | 0.080 |
Why?
|
| Nasal Obstruction | 1 | 2010 | 1 | 0.080 |
Why?
|
| Edema | 1 | 2010 | 5 | 0.080 |
Why?
|
| Hemorrhage | 1 | 2010 | 18 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2010 | 12 | 0.080 |
Why?
|
| Wound Healing | 1 | 2009 | 13 | 0.080 |
Why?
|
| Hypopharynx | 1 | 2009 | 1 | 0.080 |
Why?
|
| Larynx | 1 | 2009 | 3 | 0.080 |
Why?
|
| Vascular Malformations | 1 | 2009 | 2 | 0.080 |
Why?
|
| Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2006 | 1 | 0.060 |
Why?
|
| Critical Pathways | 1 | 2019 | 1 | 0.040 |
Why?
|
| Hospitals, Public | 1 | 2019 | 3 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 7 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 13 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 11 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 16 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 12 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2018 | 85 | 0.040 |
Why?
|
| Survival Rate | 1 | 2016 | 92 | 0.030 |
Why?
|
| Ketoconazole | 1 | 2015 | 1 | 0.030 |
Why?
|
| Mitotane | 1 | 2015 | 1 | 0.030 |
Why?
|
| Cytochrome P-450 CYP3A Inhibitors | 1 | 2015 | 1 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 8 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2015 | 36 | 0.030 |
Why?
|
| Hearing Aids | 1 | 2014 | 1 | 0.030 |
Why?
|
| Directive Counseling | 1 | 2014 | 3 | 0.030 |
Why?
|
| Audiometry | 1 | 2014 | 2 | 0.030 |
Why?
|
| New York | 1 | 2014 | 5 | 0.030 |
Why?
|
| Complementary Therapies | 1 | 2014 | 9 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 92 | 0.030 |
Why?
|
| Accountable Care Organizations | 1 | 2014 | 1 | 0.030 |
Why?
|
| Health Care Reform | 1 | 2014 | 4 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2014 | 18 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 407 | 0.030 |
Why?
|
| ROC Curve | 1 | 2011 | 24 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 45 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 83 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2011 | 1 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2011 | 5 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2011 | 6 | 0.020 |
Why?
|
| Aerosols | 1 | 2011 | 11 | 0.020 |
Why?
|
| Papillomavirus Infections | 1 | 2011 | 22 | 0.020 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2010 | 13 | 0.020 |
Why?
|
| Glottis | 1 | 2009 | 1 | 0.020 |
Why?
|
| Laryngeal Mucosa | 1 | 2009 | 1 | 0.020 |
Why?
|
| Facial Transplantation | 1 | 2009 | 1 | 0.020 |
Why?
|
| Skin Physiological Phenomena | 1 | 2009 | 2 | 0.020 |
Why?
|
| Forecasting | 1 | 2009 | 15 | 0.020 |
Why?
|